21st Century Oncology, owned by debt holders, launches auction amid comeback

Almost two years after emerging from Chapter 11 bankruptcy, 21st Century Oncology is evaluating a sale that could ultimately value the newly-led cancer treatment company around $1 billion, according to people familiar with the matter.